Search The Medical Knowledge Base

Search:

Medical News by Category

Prostate Cancer News

• Enzalutamide is filed at FDA by Medivation for Prostate Cancer
  

  Published: Wednesday 23 May 2012

• NICE draft guidance now approves Zytiga (J&J Janssen Cilag) for Prostate Cancer
  

  Published: Wednesday 16 May 2012

• BIND-014 first nanomedicine to enter clinical studies
  

  Published: Tuesday 10 April 2012

• IMPACT study for Provenge (Dendreon) effect in Prostate Cancer questioned
  

  Published: Saturday 31 March 2012

• OncoGenex/Teva initiate Phase III trial for custirsen for Prostate Cancer
  

  Published: Saturday 10 March 2012

• Phase III study of Zytiga (Janssen) for Prostate Cancer unblinded
  

  Published: Saturday 10 March 2012

• Phase III Trial of MDV 3100 (Medivation/Astellas) in Prostate Cancer patients shows positive results
  

  Published: Wednesday 01 February 2012

• Zytiga (J&J Janssen Cilag) offers benefits for Prostate Cancer patients who are not eligible for docetaxel therapy
  

  Published: Wednesday 11 January 2012

• Radiotherapy combined with androgen deprivation therapy improves survival in Prostate Cancer patients
  

  Published: Monday 07 November 2011

• Phase III trial of MDV 3100 (Medivation/Astellas) shows significant benefits for patients with advanced Prostate Cancer
  

  Published: Friday 04 November 2011

• SiMoA PSA test found a reliable predictor of Prostate Cancer recurrence
  

  Published: Saturday 15 October 2011

• FDA warns that Leukemia drug Sprycel can lead to PAH
  

  Published: Thursday 13 October 2011

• NICE rejects Jevtana for Prostate Cancer
  

  Published: Monday 03 October 2011

• Provenge sales for Prostate Cancer disappoint Dendreon and lead to staff reduction
  

  Published: Friday 16 September 2011